BioPharma Credit (LON:BPCP) Trading Up 1.2% – Should You Buy?

BioPharma Credit PLC (LON:BPCPGet Free Report)’s stock price traded up 1.2% during trading on Thursday . The company traded as high as GBX 70.80 ($0.88) and last traded at GBX 70.12 ($0.87). 41,924 shares were traded during mid-day trading, an increase of 75% from the average session volume of 23,988 shares. The stock had previously closed at GBX 69.30 ($0.86).

BioPharma Credit Price Performance

The company has a 50-day moving average of GBX 68.40 and a 200 day moving average of GBX 68.39. The company has a market cap of £967.22 million, a PE ratio of 1,176.67 and a beta of 0.22.

About BioPharma Credit

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.